Literature DB >> 26686670

Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.

Elliott J Mufson1, Michael Malek-Ahmadi2, Sylvia E Perez3, Kewei Chen2.   

Abstract

Clinico-pathological studies reveal that some elderly people with no cognitive impairment have high burdens of neurofibrillary tangles (NFTs), a pathology associated with Alzheimer's disease. We examined a total of 123 elderly participants without dementia and free of other neurological disorders or pathologies who at autopsy were classified as Braak NFT stages of I-V. We found that women were significantly more likely to have a high Braak score. Significant associations were found between high Braak scores and entorhinal cortex amyloid load, combined hippocampal and entorhinal cortex amyloid loads with perceptual speed in the low Braak group after adjusting for age, gender and apolipoprotein E ε4 status. Elderly with preserved cognitive function show a wide range of Braak scores and plaque pathology similar to that seen in prodromal and frank Alzheimer's disease at death. These data suggest that some older people with extensive NFT and plaque pathology demonstrate brain resilience or reserve leading to preserved cognitive function.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer's; Amyloid; Dementia; Neurofibrillary tangles; Neuropathology

Mesh:

Substances:

Year:  2015        PMID: 26686670      PMCID: PMC4687022          DOI: 10.1016/j.neurobiolaging.2015.10.012

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  41 in total

Review 1.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

2.  Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment.

Authors:  T W Mitchell; J Nissanov; L Y Han; E J Mufson; J A Schneider; E J Cochran; D A Bennett; V M Lee; J Q Trojanowski; S E Arnold
Journal:  J Histochem Cytochem       Date:  2000-12       Impact factor: 2.479

3.  Clinical validity of Braak neuropathological staging in the oldest-old.

Authors:  G Gold; C Bouras; E Kövari; A Canuto; B G Glaría; A Malky; P R Hof; J P Michel; P Giannakopoulos
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

4.  Factors associated with resistance to dementia despite high Alzheimer disease pathology.

Authors:  D Erten-Lyons; R L Woltjer; H Dodge; R Nixon; R Vorobik; J F Calvert; M Leahy; T Montine; J Kaye
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

5.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

6.  Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death.

Authors:  Joseph H Su; Aileen J Anderson; David H Cribbs; Christina Tu; Liqi Tong; Patrick Kesslack; Carl W Cotman
Journal:  Neurobiol Dis       Date:  2003-04       Impact factor: 5.996

7.  Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.

Authors:  Angela L Guillozet; Sandra Weintraub; Deborah C Mash; M Marsel Mesulam
Journal:  Arch Neurol       Date:  2003-05

Review 8.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

9.  Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.

Authors:  Vahram Haroutunian; Michal Schnaider-Beeri; James Schmeidler; Michael Wysocki; Dushyant P Purohit; Daniel P Perl; Leslie S Libow; Gerson T Lesser; Maria Maroukian; Hillel T Grossman
Journal:  Arch Neurol       Date:  2008-09

10.  Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

Authors:  David A Bennett; Julie A Schneider; Robert S Wilson; Julia L Bienias; Steven E Arnold
Journal:  Arch Neurol       Date:  2004-03
View more
  20 in total

1.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

2.  Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.

Authors:  Takashi Mori; Naoki Koyama; Jun Tan; Tatsuya Segawa; Masahiro Maeda; Terrence Town
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

3.  Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or β-Amyloidosis.

Authors:  Jerzy Wegiel; Michael Flory; Izabela Kuchna; Krzysztof Nowicki; Shuang Yong Ma; Jarek Wegiel; Eulalia Badmaev; Wayne P Silverman; Mony de Leon; Barry Reisberg; Thomas Wisniewski
Journal:  J Neuropathol Exp Neurol       Date:  2017-06-01       Impact factor: 3.685

Review 4.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

5.  Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.

Authors:  Takashi Mori; Naoki Koyama; Tomotaka Yokoo; Tatsuya Segawa; Masahiro Maeda; Darrell Sawmiller; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

Review 6.  Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

Authors:  Elliott J Mufson; Milos D Ikonomovic; Scott E Counts; Sylvia E Perez; Michael Malek-Ahmadi; Stephen W Scheff; Stephen D Ginsberg
Journal:  Behav Brain Res       Date:  2016-05-13       Impact factor: 3.332

Review 7.  Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies.

Authors:  Olga Zolochevska; Giulio Taglialatela
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

8.  Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Authors:  Stephen W Scheff; Mubeen A Ansari; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

9.  Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Shaoli Che; Irina Elarova; Yinghua Chen; Freddy Jeanneteau; Thorsten M Kranz; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Hippocampus       Date:  2017-09-27       Impact factor: 3.899

10.  Braak stage and trajectory of cognitive decline in noncognitively impaired elders.

Authors:  Elliott J Mufson; Michael Malek-Ahmadi; Noelle Snyder; Jake Ausdemore; Kewei Chen; Sylvia E Perez
Journal:  Neurobiol Aging       Date:  2016-03-10       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.